The Patent Finder

Terms ending in 2040

Abraxis Bioscience, LLC

Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,944,708Methods of Treating Central Nervous System Disorders via Administration of Nanoparticles of an Mtor Inhibitor and an Albumin
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 11,497,737Pharmaceutical Compositions of Albumin and Rapamycin
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited